This suggests that inhibition of diabetes-induced retinal molecular modifications and pathological changes in the RPE of Akt2 cKO mice may be due to the upregulation of Akt1 and the downstream inhibition of the GSK3β/NF-κB regulated inflammatory response. The gene discussed is AKT1; the disease is diabetes mellitus.